|

Reducing Urban Cervical Cancer Disparities

RECRUITINGN/ASponsored by Fox Chase Cancer Center
Actively Recruiting
PhaseN/A
SponsorFox Chase Cancer Center
Started2024-08-28
Est. completion2027-04
Eligibility
Age18 Years – 90 Years
SexFEMALE
Healthy vol.Accepted
Locations3 sites

Summary

This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.

Eligibility

Age: 18 Years – 90 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
* referral for colposcopic evaluation at the clinic sites,
* able to communicate with ease in English,
* have a cell phone with texting ability, and
* competent to give consent.

Exclusion Criteria:

* are pregnant at the time of recruitment,
* display current evidence or have a history of positive invasive carcinoma of the cervix, or
* require follow-up but not a colposcopy.

Conditions3

CancerCervical CancerPapilloma Viral Infection

Locations3 sites

New Jersey

1 site
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, 08901
Shawna Hudson, PhD(848) 932-0215hudsonsh@rutgers.edu

Pennsylvania

2 sites
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
Kuang-Yi Wen, PhD215-503-4623kuang-yi.wen@jefferson.edu
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
Erin Tagai, PhD, MPH215-728-5621erin.tagai@fccc.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.